CDKN2B-AS1 and prostate carcinoma: The prostate cancer risk-associated variant at this locus, rs17694493, is predicted to disrupt the binding motifs of transcription factors STAT1 and RUNX1 and positioned in the intronic region of a novel lncRNA gene CDKN2B-AS1 (also known as ANRIL).